Responses
Oncolytic and local immunotherapy
Original research
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.